This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Revolution Medicines, Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Meghan A. Rice
Introduction
Meghan A. Rice is a prominent inventor based in Belmont, California. She has made significant strides in the field of cancer treatment through her innovative research and development. Her work focuses on the inhibition of Ras proteins, which play a crucial role in cancer progression.
Latest Patents
Meghan A. Rice holds 1 patent for her invention related to Ras inhibitors. The patent features macrocyclic compounds, pharmaceutical compositions, and protein complexes capable of inhibiting Ras proteins. This groundbreaking work has potential applications in the treatment of various cancers, showcasing her commitment to advancing medical science.
Career Highlights
Throughout her career, Meghan has demonstrated exceptional expertise in her field. She is currently associated with Revolution Medicines, Inc., where she continues to contribute to innovative cancer therapies. Her dedication to research and development has positioned her as a key figure in the fight against cancer.
Collaborations
Meghan has collaborated with notable colleagues, including Naing N. Aay and G. Leslie Burnett. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in cancer treatment.
Conclusion
Meghan A. Rice's contributions to the field of cancer research through her innovative patents and collaborations highlight her as a leading inventor. Her work not only advances scientific knowledge but also holds promise for improving patient outcomes in cancer treatment.